These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11490508)

  • 1. [Acute therapy of heart failure with nitroglycerin. Rapid help in routine practice].
    Bussmann WD
    MMW Fortschr Med; 2001 Apr; 143(17):45. PubMed ID: 11490508
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute decompensated heart failure.
    Nemeth J
    CMAJ; 2007 Jul; 177(2):175; author reply 175-6. PubMed ID: 17638958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic effects of nitroglycerin in oral form (Nitrilex Spray)].
    Stejfa M; Vítovec J; Roubalík P; Blaha M
    Vnitr Lek; 1988 Mar; 34(3):237-44. PubMed ID: 3130719
    [No Abstract]   [Full Text] [Related]  

  • 4. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Emergency care in acute left heart failure. Decreasing preload, oxygen inhalation].
    Herholz C
    MMW Fortschr Med; 2001 Sep; 143(37):38-40. PubMed ID: 11599290
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW; Howlett JG
    Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute nitrate--essential in coronary heart disease].
    MMW Fortschr Med; 2009 Jun; 151(25):48-9. PubMed ID: 19739525
    [No Abstract]   [Full Text] [Related]  

  • 8. Buccal nitroglycerin in elderly patients with congestive cardiac failure.
    Sanghera SS; Goldberg AA; Parsons DG
    Practitioner; 1985 Dec; 229(1410):1054-5. PubMed ID: 3937151
    [No Abstract]   [Full Text] [Related]  

  • 9. New nitroglycerin formulations: transdermal and transmucosal nitroglycerin.
    Abrams J
    Z Kardiol; 1985; 74 Suppl 4():10-5. PubMed ID: 3938113
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nitrate derivatives and congestive cardiac failure in infants. Pharmacological efficacy of transcutaneous administration devices].
    Guillot M; Braud J; Leveque C; Rey E; Olive G; Iselin M
    Arch Fr Pediatr; 1986 Jan; 43(1):67. PubMed ID: 3085627
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
    Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R
    Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute decompensated heart failure: the shrinking role of inotropic therapy.
    Dec GW
    J Am Coll Cardiol; 2005 Jul; 46(1):65-7. PubMed ID: 15992637
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nitroglycerin].
    Blumenberg D
    Krankenpfl J; 1990 Mar; 28(3):103-5. PubMed ID: 2109809
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal starting time of acquisition and feasibility of complementary administration of nitroglycerin with intravenous beta-blocker in multislice computed tomography.
    Sato K; Isobe S; Sugiura K; Mimura T; Yotsudake Y; Meno C; Kato M; Harada K; Murohara T
    J Comput Assist Tomogr; 2009; 33(2):193-8. PubMed ID: 19346844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response.
    Gisolf J; Westerhof BE; van Dijk N; Wesseling KH; Wieling W; Karemaker JM
    J Am Coll Cardiol; 2004 Aug; 44(3):588-93. PubMed ID: 15358026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do medications affect vital signs in the prehospital treatment of acute decompensated heart failure?
    Sporer KA; Tabas JA; Tam RK; Sellers KL; Rosenson J; Barton CW; Pletcher MJ
    Prehosp Emerg Care; 2006; 10(1):41-5. PubMed ID: 16418090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of current noninodilator therapies for acute heart failure syndromes.
    Stough WG; O'Connor CM; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the numeric descriptive scale for pain after sublingual nitroglycerin do not predict cardiac etiology of chest pain.
    Diercks DB; Boghos E; Guzman H; Amsterdam EA; Kirk JD
    Ann Emerg Med; 2005 Jun; 45(6):581-5. PubMed ID: 15940087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.